z-logo
open-access-imgOpen Access
Plasma Dickkopf1 (DKK1) Concentrations Negatively Associate with Atherosclerotic Calcified Plaque in African-Americans with Type 2 Diabetes
Author(s) -
Thomas C. Register,
Keith A. Hruska,
Jasmin Divers,
Donald W. Bowden,
Nicholette D. Palmer,
J. Jeffrey Carr,
Lynne E. Wagenknecht,
R. Caresse Hightower,
Jianzhao Xu,
S. Carrie Smith,
Dennis J. Dietzen,
Carl D. Langefeld,
Barry I. Freedman
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3038
Subject(s) - medicine , cardiology , bone mineral , body mass index , endocrinology , diabetes mellitus , type 2 diabetes , artery , coronary artery disease , osteoporosis
Bone mineral density (BMD) and atherosclerotic arterial calcified plaque (CP) demonstrate inverse relationships through unknown mechanisms. Dickkopf-1 (DKK1) is an endogenous inhibitor of bone formation, and serum DKK1 has been associated with impaired osteoblast activation and susceptibility to bone loss. Plasma DKK1, BMD in the spine, and CP in three arterial beds were assessed in African-Americans (AAs) to determine relationships of serum DKK1 with atherosclerotic vascular calcification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom